WHO ICTRP trial

Investigation of the effect of Dimethyl fumarate on T cells in patients with…

EUCTR2014-003481-25-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2014-003481-25-DE
Public title Investigation of the effect of Dimethyl fumarate on T cells in patients with relapsing remitting Multiple Sclerosis
Scientific title A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on Immune-Modulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis - DIMAT-MS
Primary sponsor Universitätsklinikum Münster
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Germany
Conditions relapsing remitting multiple sclerosis MedDRA version: 19.1 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C]…
Interventions Trade Name: Tecfidera® 120mg magensaftresistente Hartkapseln Pharmaceutical Form: Gastro-resistant capsule, hard INN or Proposed INN: Dimethyl fumarate CAS Number: 624-49-7 Other descriptive name: DIMETHYL FUMARATE Concentration unit: mg…
Registration date Feb 17, 2015
Target size 67
Secondary IDs DIMAT-MS
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations